TD Asset Management Inc Sells 58,658 Shares of The Cooper Companies, Inc. $COO

TD Asset Management Inc lowered its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 7.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 700,036 shares of the medical device company’s stock after selling 58,658 shares during the period. TD Asset Management Inc’s holdings in Cooper Companies were worth $57,375,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the business. New York Life Investment Management LLC raised its stake in shares of Cooper Companies by 0.6% during the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after acquiring an additional 158 shares during the last quarter. Root Financial Partners LLC raised its stake in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the last quarter. Allworth Financial LP raised its stake in shares of Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after acquiring an additional 167 shares during the last quarter. Mesirow Financial Investment Management Inc. raised its stake in shares of Cooper Companies by 1.3% during the third quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after acquiring an additional 175 shares during the last quarter. Finally, Blue Trust Inc. raised its stake in shares of Cooper Companies by 13.9% during the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after acquiring an additional 185 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 8.6%

COO opened at $67.34 on Friday. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The company has a fifty day moving average of $65.09 and a 200-day moving average of $74.52. The stock has a market cap of $13.14 billion, a PE ratio of 57.07, a price-to-earnings-growth ratio of 1.60 and a beta of 0.87.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.85%. Cooper Companies’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts predict that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on COO. Robert W. Baird dropped their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday. Mizuho set a $85.00 price objective on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday. Wells Fargo & Company reiterated a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research report on Friday. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research report on Friday. Finally, Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $82.64.

More Cooper Companies News

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Cooper Companies posted better-than-expected Q2 results, with EPS of $1.21 topping estimates of $1.10 and revenue of $1.08 billion beating forecasts, while sales rose 7.9% year over year. CooperCompanies Announces Second Quarter 2026 Results
• Positive Sentiment: Management said it reached agreements to resolve substantially all claims tied to the prior fertility media recall, reducing a major legal overhang and supporting investor confidence in the company’s outlook. QuiverQuant article
• Positive Sentiment: Needham reaffirmed a Buy rating on COO and lowered its price target to $86, still implying meaningful upside from current levels. TipRanks analyst update
• Positive Sentiment: Stifel, Baird, and JPMorgan all cut price targets but kept constructive ratings, suggesting analysts see the report as solid even after valuation resets. Benzinga analyst update
• Neutral Sentiment: The company guided FY2026 EPS to $4.58-$4.66, slightly around consensus, which helps confirm expectations but does not point to a major near-term surprise. Earnings report transcript
• Negative Sentiment: JPMorgan lowered its price target on COO from $80 to $71 and kept a Neutral rating, reflecting more cautious expectations despite the stock’s recent strength. JPMorgan price target update

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.